| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ERCC6 SMCHD1 KIF21A HSPH1 ATP1A2 MTREX HSPA5 ATP4B DDX1 | 1.54e-05 | 614 | 61 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 5.49e-05 | 4 | 61 | 2 | GO:0047655 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.61e-05 | 441 | 61 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | cadherin binding | 7.59e-05 | 339 | 61 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I binding | 9.13e-05 | 5 | 61 | 2 | GO:0034186 | |
| GeneOntologyMolecularFunction | enzyme activator activity | ARFGAP2 ERCC6 PSME4 UBE2N DBF4B ARHGAP12 ARFGAP1 RICTOR ARHGAP45 | 1.59e-04 | 656 | 61 | 9 | GO:0008047 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 1.96e-04 | 37 | 61 | 3 | GO:0061631 | |
| GeneOntologyMolecularFunction | molecular function activator activity | VEGFC ARFGAP2 ERCC6 PSME4 UBE2N DBF4B ARHGAP12 ARFGAP1 PRKACA RICTOR ARHGAP45 ATP4B | 3.02e-04 | 1233 | 61 | 12 | GO:0140677 |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 3.07e-04 | 43 | 61 | 3 | GO:0061650 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 3.22e-04 | 107 | 61 | 4 | GO:0043130 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 4.96e-04 | 11 | 61 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 5.42e-04 | 775 | 61 | 9 | GO:0017111 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 6.34e-04 | 128 | 61 | 4 | GO:0032182 | |
| GeneOntologyMolecularFunction | lipid binding | ABCA1 NSFL1C SCARB1 AKR1B15 FNBP1L ATP1A2 ACBD6 SCIN MCTP2 GSN | 7.61e-04 | 988 | 61 | 10 | GO:0008289 |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.16e-04 | 14 | 61 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 8.16e-04 | 14 | 61 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | high-density lipoprotein particle binding | 9.40e-04 | 15 | 61 | 2 | GO:0008035 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 9.40e-04 | 15 | 61 | 2 | GO:0052650 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 9.53e-04 | 839 | 61 | 9 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 9.62e-04 | 840 | 61 | 9 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.62e-04 | 840 | 61 | 9 | GO:0016818 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 1.21e-03 | 17 | 61 | 2 | GO:0005545 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.68e-03 | 20 | 61 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.26e-03 | 599 | 61 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 3.07e-03 | 27 | 61 | 2 | GO:0008106 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 3.65e-03 | 337 | 61 | 5 | GO:0031625 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.29e-03 | 32 | 61 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.53e-03 | 109 | 61 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 4.71e-03 | 358 | 61 | 5 | GO:0044389 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 5.12e-03 | 35 | 61 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 5.12e-03 | 35 | 61 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 5.41e-03 | 36 | 61 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 5.41e-03 | 36 | 61 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | phospholipid binding | 6.44e-03 | 548 | 61 | 6 | GO:0005543 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 6.65e-03 | 40 | 61 | 2 | GO:0140662 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.01e-06 | 396 | 60 | 9 | GO:0051235 | |
| GeneOntologyCellularComponent | ubiquitin conjugating enzyme complex | 1.96e-06 | 9 | 61 | 3 | GO:0031371 | |
| GeneOntologyCellularComponent | HULC complex | 5.01e-05 | 4 | 61 | 2 | GO:0033503 | |
| GeneOntologyCellularComponent | sex chromosome | 2.88e-04 | 44 | 61 | 3 | GO:0000803 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 5.43e-04 | 12 | 61 | 2 | GO:0005890 | |
| Domain | UBQ-conjugating_AS | 7.24e-05 | 25 | 61 | 3 | IPR023313 | |
| Domain | UQ_con | 2.79e-04 | 39 | 61 | 3 | PF00179 | |
| Domain | Villin/Gelsolin | 2.90e-04 | 8 | 61 | 2 | IPR007122 | |
| Domain | GEL | 2.90e-04 | 8 | 61 | 2 | SM00262 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 3.00e-04 | 40 | 61 | 3 | PS00183 | |
| Domain | UBQ-conjugat_E2 | 3.23e-04 | 41 | 61 | 3 | IPR000608 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 3.23e-04 | 41 | 61 | 3 | PS50127 | |
| Domain | ALDOKETO_REDUCTASE_1 | 4.64e-04 | 10 | 61 | 2 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 4.64e-04 | 10 | 61 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 4.64e-04 | 10 | 61 | 2 | IPR020471 | |
| Domain | EF-hand_4 | 4.64e-04 | 10 | 61 | 2 | PF12763 | |
| Domain | ALDOKETO_REDUCTASE_2 | 4.64e-04 | 10 | 61 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 4.64e-04 | 10 | 61 | 2 | PS00063 | |
| Domain | EH | 5.66e-04 | 11 | 61 | 2 | PS50031 | |
| Domain | EH | 5.66e-04 | 11 | 61 | 2 | SM00027 | |
| Domain | EH_dom | 5.66e-04 | 11 | 61 | 2 | IPR000261 | |
| Domain | - | 6.17e-04 | 51 | 61 | 3 | 3.10.110.10 | |
| Domain | - | 6.78e-04 | 12 | 61 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 6.78e-04 | 12 | 61 | 2 | IPR029047 | |
| Domain | UBQ-conjugating_enzyme/RWD | 6.91e-04 | 53 | 61 | 3 | IPR016135 | |
| Domain | - | 8.00e-04 | 13 | 61 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 8.00e-04 | 13 | 61 | 2 | IPR018181 | |
| Domain | HSP70_C | 8.00e-04 | 13 | 61 | 2 | IPR029048 | |
| Domain | Gelsolin | 9.31e-04 | 14 | 61 | 2 | PF00626 | |
| Domain | Gelsolin-like_dom | 9.31e-04 | 14 | 61 | 2 | IPR007123 | |
| Domain | - | 1.22e-03 | 16 | 61 | 2 | 3.20.20.100 | |
| Domain | HSP70 | 1.22e-03 | 16 | 61 | 2 | PF00012 | |
| Domain | NADP_OxRdtase_dom | 1.38e-03 | 17 | 61 | 2 | IPR023210 | |
| Domain | HSP70_2 | 1.38e-03 | 17 | 61 | 2 | PS00329 | |
| Domain | Aldo_ket_red | 1.38e-03 | 17 | 61 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.38e-03 | 17 | 61 | 2 | IPR001395 | |
| Domain | HSP70_3 | 1.38e-03 | 17 | 61 | 2 | PS01036 | |
| Domain | HSP70_1 | 1.38e-03 | 17 | 61 | 2 | PS00297 | |
| Domain | Hsp_70_fam | 1.55e-03 | 18 | 61 | 2 | IPR013126 | |
| Domain | FCH | 2.32e-03 | 22 | 61 | 2 | SM00055 | |
| Domain | FCH_dom | 2.54e-03 | 23 | 61 | 2 | IPR001060 | |
| Domain | ADF-H/Gelsolin-like_dom | 2.77e-03 | 24 | 61 | 2 | IPR029006 | |
| Domain | - | 2.77e-03 | 24 | 61 | 2 | 3.40.20.10 | |
| Domain | F_BAR | 3.00e-03 | 25 | 61 | 2 | IPR031160 | |
| Domain | F_BAR | 3.00e-03 | 25 | 61 | 2 | PS51741 | |
| Domain | ArfGap | 4.02e-03 | 29 | 61 | 2 | SM00105 | |
| Domain | ArfGap | 4.02e-03 | 29 | 61 | 2 | PF01412 | |
| Domain | ARFGAP | 4.02e-03 | 29 | 61 | 2 | PS50115 | |
| Domain | ArfGAP | 4.02e-03 | 29 | 61 | 2 | IPR001164 | |
| Domain | Helicase_C | 5.17e-03 | 107 | 61 | 3 | PF00271 | |
| Domain | HELICc | 5.17e-03 | 107 | 61 | 3 | SM00490 | |
| Domain | Helicase_C | 5.31e-03 | 108 | 61 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.44e-03 | 109 | 61 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.44e-03 | 109 | 61 | 3 | PS51192 | |
| Domain | DEXDc | 5.44e-03 | 109 | 61 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.58e-03 | 110 | 61 | 3 | IPR014001 | |
| Pubmed | EPS15 ARFGAP2 EPS15L1 EEF1G NSFL1C EIF2S3 AHNAK ARHGAP12 EGLN1 HSPH1 ARFGAP1 RICTOR RAI14 HSPA5 | 1.72e-11 | 708 | 61 | 14 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPS15 EPS15L1 EEF1G PDPR UBE2N AHNAK KIF21A HSPH1 ARFGAP1 PYGL RAI14 FNBP1L TACC3 NSUN2 HSPA5 GSN | 1.14e-09 | 1367 | 61 | 16 | 32687490 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EPS15 ARFGAP2 EPS15L1 EEF1G NSFL1C EIF2S3 AHNAK SCARB1 RAI14 FNBP1L HSPA5 | 3.79e-09 | 565 | 61 | 11 | 25468996 |
| Pubmed | CCDC134 MEST EEF1G UBE2B UBE2N EIF2S3 SMCHD1 AHNAK KIF21A SCARB1 HSPH1 ARFGAP1 PRKACA RAI14 HSPA5 | 4.87e-09 | 1297 | 61 | 15 | 33545068 | |
| Pubmed | EPS15 ARFGAP2 EPS15L1 EEF1G NSFL1C AHNAK HSPH1 ARFGAP1 SLC33A1 HSPA5 | 5.83e-09 | 449 | 61 | 10 | 31732153 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPALPP1 EPS15 EPS15L1 EEF1G EIF2S3 SMCHD1 AHNAK EGLN1 HSPH1 ARFGAP1 RAI14 SCIN NSUN2 | 6.94e-09 | 934 | 61 | 13 | 33916271 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EEF1G ERCC6 PSME4 NSFL1C SMCHD1 AHNAK KIF21A HSPH1 PYGL RICTOR RAI14 MTREX NSUN2 HSPA5 DDX1 | 8.58e-09 | 1353 | 61 | 15 | 29467282 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPS15 EEF1G NSFL1C EIF2S3 AHNAK HSPH1 PRKACA PYGL RAI14 AKR1B1 NSUN2 HSPA5 DDX1 GSN | 9.02e-09 | 1149 | 61 | 14 | 35446349 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PHF2 EPS15L1 EEF1G EIF2S3 KIF21A HSPH1 ARFGAP1 PRKACA PYGL HSPA5 GSN | 1.00e-08 | 621 | 61 | 11 | 22794259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPS15 EPS15L1 EEF1G PSME4 NSFL1C EIF2S3 AHNAK KIF21A HSPH1 ARFGAP1 PRKACA PYGL NSUN2 HSPA5 DDX1 | 2.25e-08 | 1455 | 61 | 15 | 22863883 |
| Pubmed | GPALPP1 PHF2 EEF1G NSFL1C EIF2S3 SMCHD1 HSPH1 PYGL MTREX NSUN2 DDX1 GSN RAI1 | 4.90e-08 | 1103 | 61 | 13 | 34189442 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GPALPP1 PHF2 EEF1G NSFL1C UBE2N EIF2S3 SMCHD1 AHNAK HSPH1 PYGL MTREX NSUN2 HSPA5 DDX1 | 5.00e-08 | 1318 | 61 | 14 | 30463901 |
| Pubmed | 9.13e-08 | 63 | 61 | 5 | 17220478 | ||
| Pubmed | EPS15 ARFGAP2 EPS15L1 EEF1G EIF2S3 AHNAK EGLN1 ARFGAP1 RICTOR RAI14 TACC3 | 9.76e-08 | 777 | 61 | 11 | 35844135 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 15383616 | ||
| Pubmed | GPALPP1 PHF2 EPS15L1 NSFL1C SMCHD1 AHNAK RAI14 AKR1B1 MED13 RAI1 | 1.73e-07 | 645 | 61 | 10 | 25281560 | |
| Pubmed | EEF1G NSFL1C UBE2N EIF2S3 KIF21A HSPH1 RAI14 TEAD3 MTREX NSUN2 HSPA5 MED13 DDX1 | 2.01e-07 | 1247 | 61 | 13 | 27684187 | |
| Pubmed | 3.50e-07 | 529 | 61 | 9 | 14621295 | ||
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 3.75e-07 | 159 | 61 | 6 | 36762613 | |
| Pubmed | 5.29e-07 | 274 | 61 | 7 | 34244482 | ||
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 8.27e-07 | 182 | 61 | 6 | 30711629 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EEF1G UBE2N EIF2S3 SMCHD1 AHNAK KIF21A HSPH1 FNBP1L MTREX NSUN2 HSPA5 DDX1 GSN | 8.41e-07 | 1415 | 61 | 13 | 28515276 |
| Pubmed | GPALPP1 SMCHD1 AHNAK KIF21A ARHGAP12 HSPH1 PRKACA FNBP1L ATP1A2 HSPA5 MED13 DDX1 RAI1 | 1.04e-06 | 1442 | 61 | 13 | 35575683 | |
| Pubmed | 1.26e-06 | 312 | 61 | 7 | 37120454 | ||
| Pubmed | GPALPP1 CCDC134 ARFGAP2 EPS15L1 NSFL1C SCARB1 ARFGAP1 ATP1A2 SLC33A1 HSPA5 DDX1 | 1.26e-06 | 1007 | 61 | 11 | 34597346 | |
| Pubmed | 1.27e-06 | 803 | 61 | 10 | 36517590 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.33e-06 | 807 | 61 | 10 | 30575818 | |
| Pubmed | EEF1G UBE2A UBE2N SMCHD1 AHNAK PYGL MTREX AKR1B1 NSUN2 MED13 DDX1 | 1.35e-06 | 1014 | 61 | 11 | 32416067 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.37e-06 | 316 | 61 | 7 | 31665637 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EEF1G ERCC6 EIF2S3 SMCHD1 AHNAK HSPH1 RAI14 MTREX NSUN2 HSPA5 DDX1 GSN | 1.60e-06 | 1257 | 61 | 12 | 36526897 |
| Pubmed | 1.83e-06 | 330 | 61 | 7 | 32529326 | ||
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 1.90e-06 | 210 | 61 | 6 | 26217791 | |
| Pubmed | 1.92e-06 | 650 | 61 | 9 | 38777146 | ||
| Pubmed | 2.18e-06 | 488 | 61 | 8 | 31324722 | ||
| Pubmed | 2.69e-06 | 223 | 61 | 6 | 20020773 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22672264 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21859969 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9819354 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19837407 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28806395 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15169909 | ||
| Pubmed | Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. | 3.03e-06 | 2 | 61 | 2 | 22802462 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12556476 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22178419 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15102890 | ||
| Pubmed | Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. | 3.03e-06 | 2 | 61 | 2 | 1717990 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16647293 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12196520 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 1559696 | ||
| Pubmed | The NMR structure of the class I human ubiquitin-conjugating enzyme 2b. | 3.03e-06 | 2 | 61 | 2 | 11885984 | |
| Pubmed | The polyphenol PGG enhances expression of SR-BI and ABCA1 in J774 and THP-1 macrophages. | 3.03e-06 | 2 | 61 | 2 | 26322417 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21840001 | ||
| Pubmed | The crystal structure of the C-terminus of adseverin reveals the actin-binding interface. | 3.03e-06 | 2 | 61 | 2 | 19666531 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31683936 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16410457 | ||
| Pubmed | New Insights into the RNA-Binding and E3 Ubiquitin Ligase Activities of Roquins. | 3.43e-06 | 17 | 61 | 3 | 26489670 | |
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 33650289 | ||
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 36563856 | ||
| Pubmed | 3.80e-06 | 707 | 61 | 9 | 19738201 | ||
| Pubmed | 4.46e-06 | 538 | 61 | 8 | 28524877 | ||
| Pubmed | CCDC134 EPS15 EPS15L1 EEF1G AHNAK ARHGAP45 MCTP2 SLC33A1 HSPA5 MED13 DDX1 | 5.24e-06 | 1168 | 61 | 11 | 19946888 | |
| Pubmed | 5.35e-06 | 65 | 61 | 4 | 34645483 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 5.58e-06 | 949 | 61 | 10 | 36574265 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 5.93e-06 | 256 | 61 | 6 | 35777956 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.93e-06 | 256 | 61 | 6 | 33397691 | |
| Pubmed | EPS15L1 EEF1G EIF2S3 HSPH1 PRKACA RAI14 BCAS1 ATP1A2 AKR1B1 HSPA5 DDX1 GSN | 6.04e-06 | 1431 | 61 | 12 | 37142655 | |
| Pubmed | 6.63e-06 | 568 | 61 | 8 | 37774976 | ||
| Pubmed | 7.72e-06 | 22 | 61 | 3 | 22797923 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 7.72e-06 | 580 | 61 | 8 | 35676659 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 7.92e-06 | 582 | 61 | 8 | 20467437 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | EEF1G EIF2S3 SMCHD1 AHNAK HSPH1 ARFGAP1 MTREX NSUN2 HSPA5 DDX1 | 8.00e-06 | 989 | 61 | 10 | 36424410 |
| Pubmed | 8.27e-06 | 156 | 61 | 5 | 37108203 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26255968 | ||
| Pubmed | Cellular physiology of cholesterol efflux in vascular endothelial cells. | 9.07e-06 | 3 | 61 | 2 | 15492319 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14685860 | ||
| Pubmed | RNF168 forms a functional complex with RAD6 during the DNA damage response. | 9.07e-06 | 3 | 61 | 2 | 23525009 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 17399905 | ||
| Pubmed | Differential developmentally regulated expression of gelsolin family members in the mouse. | 9.07e-06 | 3 | 61 | 2 | 10417819 | |
| Pubmed | ABCA1, ABCG1 and SR-BI: hormonal regulation in primary rat hepatocytes and human cell lines. | 9.07e-06 | 3 | 61 | 2 | 17241464 | |
| Pubmed | The human RAD18 gene product interacts with HHR6A and HHR6B. | 9.07e-06 | 3 | 61 | 2 | 10908344 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 25852127 | ||
| Pubmed | Differential roles of ArfGAP1, ArfGAP2, and ArfGAP3 in COPI trafficking. | 9.07e-06 | 3 | 61 | 2 | 19015319 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 17906976 | ||
| Pubmed | Cellular cholesterol transport proteins in diabetic nephropathy. | 9.07e-06 | 3 | 61 | 2 | 25181357 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21289254 | ||
| Pubmed | Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. | 9.07e-06 | 3 | 61 | 2 | 17657311 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22433860 | ||
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 9.07e-06 | 3 | 61 | 2 | 17381426 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18640393 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 27377933 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 29748333 | ||
| Pubmed | Three homologous ArfGAPs participate in coat protein I-mediated transport. | 9.07e-06 | 3 | 61 | 2 | 19299515 | |
| Pubmed | The roles of different pathways in the release of cholesterol from macrophages. | 9.07e-06 | 3 | 61 | 2 | 17761631 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12509447 | ||
| Pubmed | Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. | 9.07e-06 | 3 | 61 | 2 | 18057374 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 20018934 | ||
| Pubmed | A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. | 9.07e-06 | 3 | 61 | 2 | 11919637 | |
| Pubmed | UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4. | 9.07e-06 | 3 | 61 | 2 | 38182926 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 29853565 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21071707 | ||
| Interaction | KCNA3 interactions | EPS15 ARFGAP2 EPS15L1 EEF1G NSFL1C EIF2S3 AHNAK ARHGAP12 EGLN1 HSPH1 ARFGAP1 PYGL RICTOR RAI14 HSPA5 | 3.34e-08 | 871 | 61 | 15 | int:KCNA3 |
| Interaction | RPA4 interactions | EPS15 ARFGAP2 EEF1G PSME4 NSFL1C SMCHD1 AHNAK ARFGAP1 RICTOR HSPA5 | 9.46e-07 | 452 | 61 | 10 | int:RPA4 |
| Interaction | CAND1 interactions | ARFGAP2 EEF1G ERCC6 UBE2N EIF2S3 SCARB1 PRKACA RICTOR ATP1A2 MTREX NSUN2 HSPA5 DDX1 | 2.14e-06 | 894 | 61 | 13 | int:CAND1 |
| Interaction | CDH1 interactions | EPS15 ARFGAP2 EPS15L1 EEF1G NSFL1C EIF2S3 AHNAK SCARB1 RAI14 FNBP1L NSUN2 HSPA5 | 2.69e-06 | 768 | 61 | 12 | int:CDH1 |
| Interaction | TARDBP interactions | EEF1G NSFL1C EIF2S3 AHNAK HSPH1 RICTOR MTREX SCIN HSPA5 DDX1 | 3.32e-06 | 520 | 61 | 10 | int:TARDBP |
| Interaction | NAA40 interactions | GPALPP1 EPS15 EPS15L1 EEF1G EIF2S3 SMCHD1 AHNAK EGLN1 HSPH1 ARFGAP1 RAI14 SCIN NSUN2 | 5.73e-06 | 978 | 61 | 13 | int:NAA40 |
| Interaction | BAP1 interactions | EPS15 EEF1G EFNA2 NSFL1C EIF2S3 AHNAK HSPH1 PRKACA PYGL RAI14 AKR1B1 NSUN2 HSPA5 DDX1 GSN | 6.17e-06 | 1314 | 61 | 15 | int:BAP1 |
| Interaction | CALD1 interactions | 1.49e-05 | 265 | 61 | 7 | int:CALD1 | |
| Interaction | CEBPA interactions | GPALPP1 PHF2 EEF1G NSFL1C EIF2S3 SMCHD1 HSPH1 PYGL MTREX NSUN2 HSPA5 DDX1 GSN RAI1 | 1.59e-05 | 1245 | 61 | 14 | int:CEBPA |
| Interaction | PRPF8 interactions | EEF1G ABCA1 ERCC6 EIF2S3 AHNAK KIF21A MTREX NSUN2 HSPA5 MED13 GSN | 1.85e-05 | 776 | 61 | 11 | int:PRPF8 |
| Interaction | NBN interactions | 1.89e-05 | 183 | 61 | 6 | int:NBN | |
| Interaction | YAP1 interactions | EPS15L1 EEF1G SMCHD1 AHNAK EGLN1 HSPH1 ARFGAP1 RAI14 TEAD3 ARHGAP45 HSPA5 DDX1 GSN | 1.92e-05 | 1095 | 61 | 13 | int:YAP1 |
| Interaction | PCDH7 interactions | 2.08e-05 | 279 | 61 | 7 | int:PCDH7 | |
| Interaction | TSHB interactions | 2.08e-05 | 18 | 61 | 3 | int:TSHB | |
| Interaction | HTT interactions | PHF2 EPS15L1 EEF1G PSME4 EIF2S3 KIF21A HSPH1 ARFGAP1 PRKACA PYGL HSPA5 GSN | 2.28e-05 | 949 | 61 | 12 | int:HTT |
| Interaction | MAPT interactions | EEF1G NSFL1C UBE2N EIF2S3 AHNAK KIF21A HSPH1 PRKACA ATP1A2 AKR1B1 NSUN2 HSPA5 DDX1 | 2.41e-05 | 1119 | 61 | 13 | int:MAPT |
| Interaction | MYO6 interactions | 2.54e-05 | 398 | 61 | 8 | int:MYO6 | |
| Interaction | VASP interactions | 2.91e-05 | 294 | 61 | 7 | int:VASP | |
| Interaction | CDC42 interactions | MEST ARFGAP2 EEF1G ABCA1 NSFL1C AHNAK SCARB1 PRKACA RICTOR RAI14 FNBP1L SCIN AKR1B1 SLC33A1 | 3.14e-05 | 1323 | 61 | 14 | int:CDC42 |
| Interaction | MAP1B interactions | 3.29e-05 | 539 | 61 | 9 | int:MAP1B | |
| Interaction | PINK1 interactions | EEF1G NSFL1C AHNAK PRKACA RICTOR RAI14 TACC3 AKR1B1 HSPA5 GSN | 3.37e-05 | 679 | 61 | 10 | int:PINK1 |
| Interaction | VDAC1 interactions | 3.44e-05 | 542 | 61 | 9 | int:VDAC1 | |
| Interaction | GLDC interactions | 5.09e-05 | 321 | 61 | 7 | int:GLDC | |
| Interaction | GSK3B interactions | EEF1G NSFL1C HSPH1 PRKACA PYGL RICTOR AKR1B1 NSUN2 HSPA5 GSN RAI1 | 5.16e-05 | 868 | 61 | 11 | int:GSK3B |
| Interaction | CARM1 interactions | 5.50e-05 | 325 | 61 | 7 | int:CARM1 | |
| Interaction | NR2C2 interactions | GPALPP1 PHF2 EEF1G NSFL1C UBE2N EIF2S3 SMCHD1 AHNAK HSPH1 PYGL MTREX NSUN2 HSPA5 DDX1 | 5.97e-05 | 1403 | 61 | 14 | int:NR2C2 |
| Interaction | MSN interactions | 6.05e-05 | 330 | 61 | 7 | int:MSN | |
| Interaction | EEF1D interactions | 6.41e-05 | 333 | 61 | 7 | int:EEF1D | |
| Interaction | FBXO43 interactions | 7.46e-05 | 74 | 61 | 4 | int:FBXO43 | |
| Interaction | COMMD3 interactions | 7.46e-05 | 74 | 61 | 4 | int:COMMD3 | |
| Interaction | BRCA1 interactions | EEF1G ERCC6 UBE2N DBF4B SMCHD1 AHNAK HSPH1 ZBTB47 PYGL RICTOR TACC3 HSPA5 DDX1 | 7.52e-05 | 1249 | 61 | 13 | int:BRCA1 |
| Interaction | CEBPB interactions | EEF1G UBE2N EIF2S3 SMCHD1 AHNAK HSPH1 ARFGAP1 PYGL TACC3 MTREX AKR1B1 NSUN2 HSPA5 DDX1 | 8.08e-05 | 1443 | 61 | 14 | int:CEBPB |
| Interaction | EED interactions | ARFGAP2 EPS15L1 EEF1G UBE2N EIF2S3 SMCHD1 HSPH1 RICTOR RAI14 MTREX NSUN2 HSPA5 DDX1 GSN | 8.21e-05 | 1445 | 61 | 14 | int:EED |
| Interaction | AKR1B1 interactions | 1.06e-04 | 81 | 61 | 4 | int:AKR1B1 | |
| Interaction | KRT17 interactions | 1.12e-04 | 252 | 61 | 6 | int:KRT17 | |
| Interaction | ISG15 interactions | 1.16e-04 | 494 | 61 | 8 | int:ISG15 | |
| Interaction | LRRK2 interactions | 1.19e-04 | 496 | 61 | 8 | int:LRRK2 | |
| Interaction | PPT1 interactions | 1.23e-04 | 256 | 61 | 6 | int:PPT1 | |
| Interaction | RNF40 interactions | 1.36e-04 | 261 | 61 | 6 | int:RNF40 | |
| Interaction | UBE2M interactions | 1.40e-04 | 651 | 61 | 9 | int:UBE2M | |
| Interaction | UBA1 interactions | 1.46e-04 | 380 | 61 | 7 | int:UBA1 | |
| Interaction | FLT4 interactions | 1.71e-04 | 272 | 61 | 6 | int:FLT4 | |
| Interaction | PSMD3 interactions | 1.71e-04 | 390 | 61 | 7 | int:PSMD3 | |
| Interaction | PALS2 interactions | 1.81e-04 | 93 | 61 | 4 | int:PALS2 | |
| Interaction | NME1-NME2 interactions | 1.89e-04 | 94 | 61 | 4 | int:NME1-NME2 | |
| Interaction | NUAK1 interactions | 2.05e-04 | 96 | 61 | 4 | int:NUAK1 | |
| Interaction | RDX interactions | 2.15e-04 | 284 | 61 | 6 | int:RDX | |
| Interaction | RNF168 interactions | 2.22e-04 | 98 | 61 | 4 | int:RNF168 | |
| Interaction | PLOD3 interactions | 2.30e-04 | 183 | 61 | 5 | int:PLOD3 | |
| Interaction | AURKA interactions | EPS15 EPS15L1 UBE2N ARFGAP1 PRKACA PYGL TACC3 ARHGAP45 HSPA5 | 2.31e-04 | 696 | 61 | 9 | int:AURKA |
| Interaction | DHFR2 interactions | 2.37e-04 | 289 | 61 | 6 | int:DHFR2 | |
| Interaction | EZR interactions | 2.50e-04 | 553 | 61 | 8 | int:EZR | |
| Interaction | AHCY interactions | 2.55e-04 | 293 | 61 | 6 | int:AHCY | |
| Interaction | RNF38 interactions | 2.59e-04 | 102 | 61 | 4 | int:RNF38 | |
| Interaction | FAM20C interactions | 2.61e-04 | 188 | 61 | 5 | int:FAM20C | |
| Interaction | MIB1 interactions | 2.64e-04 | 295 | 61 | 6 | int:MIB1 | |
| Interaction | LMTK3 interactions | 2.68e-04 | 103 | 61 | 4 | int:LMTK3 | |
| Interaction | IFI16 interactions | 2.79e-04 | 714 | 61 | 9 | int:IFI16 | |
| Interaction | SNCA interactions | 2.85e-04 | 716 | 61 | 9 | int:SNCA | |
| Interaction | LIMA1 interactions | 3.05e-04 | 429 | 61 | 7 | int:LIMA1 | |
| Interaction | EFTUD2 interactions | EEF1G UBE2N EIF2S3 SMCHD1 AHNAK KIF21A HSPH1 FNBP1L MTREX NSUN2 HSPA5 MED13 DDX1 | 3.30e-04 | 1449 | 61 | 13 | int:EFTUD2 |
| Interaction | UBQLN1 interactions | 3.81e-04 | 445 | 61 | 7 | int:UBQLN1 | |
| Interaction | SUMO2 interactions | 3.91e-04 | 591 | 61 | 8 | int:SUMO2 | |
| Interaction | FGD5 interactions | 4.06e-04 | 207 | 61 | 5 | int:FGD5 | |
| Interaction | MYH9 interactions | 4.15e-04 | 754 | 61 | 9 | int:MYH9 | |
| Interaction | NDN interactions | 4.24e-04 | 453 | 61 | 7 | int:NDN | |
| Interaction | DPYSL2 interactions | 4.57e-04 | 327 | 61 | 6 | int:DPYSL2 | |
| Interaction | AGR2 interactions | 4.57e-04 | 934 | 61 | 10 | int:AGR2 | |
| Interaction | INPPL1 interactions | 4.73e-04 | 214 | 61 | 5 | int:INPPL1 | |
| Interaction | HSF1 interactions | 4.77e-04 | 609 | 61 | 8 | int:HSF1 | |
| Interaction | PHLPP1 interactions | 5.03e-04 | 333 | 61 | 6 | int:PHLPP1 | |
| Interaction | CDK2 interactions | 5.46e-04 | 783 | 61 | 9 | int:CDK2 | |
| Interaction | SEC24A interactions | 5.82e-04 | 224 | 61 | 5 | int:SEC24A | |
| Interaction | RAD23A interactions | 5.82e-04 | 224 | 61 | 5 | int:RAD23A | |
| Interaction | RNF167 interactions | 5.86e-04 | 54 | 61 | 3 | int:RNF167 | |
| Interaction | BTF3 interactions | 6.31e-04 | 799 | 61 | 9 | int:BTF3 | |
| Interaction | ARHGAP24 interactions | 6.44e-04 | 486 | 61 | 7 | int:ARHGAP24 | |
| Interaction | HK1 interactions | 7.09e-04 | 234 | 61 | 5 | int:HK1 | |
| Interaction | NDRG1 interactions | 7.22e-04 | 235 | 61 | 5 | int:NDRG1 | |
| Interaction | AR interactions | 7.31e-04 | 992 | 61 | 10 | int:AR | |
| Interaction | TRIM23 interactions | 7.57e-04 | 360 | 61 | 6 | int:TRIM23 | |
| Interaction | DHX15 interactions | 7.79e-04 | 502 | 61 | 7 | int:DHX15 | |
| Interaction | RNF123 interactions | 7.86e-04 | 824 | 61 | 9 | int:RNF123 | |
| Interaction | NCKIPSD interactions | 7.90e-04 | 137 | 61 | 4 | int:NCKIPSD | |
| Interaction | AKR1B15 interactions | 8.01e-04 | 14 | 61 | 2 | int:AKR1B15 | |
| Interaction | KCTD13 interactions | EPS15L1 EEF1G NSFL1C EIF2S3 HSPH1 PRKACA RAI14 BCAS1 AKR1B1 HSPA5 DDX1 GSN | 8.37e-04 | 1394 | 61 | 12 | int:KCTD13 |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.74e-04 | 41 | 48 | 3 | 102 | |
| GeneFamily | Gelsolin/villins | 1.91e-04 | 8 | 48 | 2 | 950 | |
| GeneFamily | Aldo-keto reductases | 7.09e-04 | 15 | 48 | 2 | 399 | |
| GeneFamily | Heat shock 70kDa proteins | 9.15e-04 | 17 | 48 | 2 | 583 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.69e-03 | 23 | 48 | 2 | 1288 | |
| GeneFamily | ArfGAPs | 3.46e-03 | 33 | 48 | 2 | 395 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 7.80e-03 | 50 | 48 | 2 | 721 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN | 7.17e-06 | 200 | 61 | 6 | M4062 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 1.07e-05 | 458 | 61 | 8 | M40010 | |
| Coexpression | ISSAEVA_MLL2_TARGETS | 1.25e-05 | 61 | 61 | 4 | M2281 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 4.41e-05 | 167 | 61 | 5 | M361 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 6.81e-05 | 183 | 61 | 5 | M8189 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_NKCELL_UP | 9.87e-05 | 198 | 61 | 5 | M5420 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.01e-04 | 199 | 61 | 5 | M5251 | |
| Coexpression | GSE7460_CD8_TCELL_VS_TREG_ACT_DN | 1.01e-04 | 199 | 61 | 5 | M5684 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 1.01e-04 | 199 | 61 | 5 | M5620 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.02e-04 | 466 | 61 | 7 | M13522 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN | 1.03e-04 | 200 | 61 | 5 | M5052 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP | 1.03e-04 | 200 | 61 | 5 | M4568 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 1.03e-04 | 200 | 61 | 5 | M6485 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN | 1.03e-04 | 200 | 61 | 5 | M3607 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN | 1.03e-04 | 200 | 61 | 5 | M5600 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN | 1.03e-04 | 200 | 61 | 5 | M3895 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_DN | 1.45e-04 | 215 | 61 | 5 | M19666 | |
| Coexpression | GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS | 1.51e-04 | 115 | 61 | 4 | M43621 | |
| Coexpression | BUSSLINGER_GASTRIC_MATURE_PIT_CELLS | 1.76e-04 | 224 | 61 | 5 | M40013 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-07 | 198 | 61 | 6 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 159 | 61 | 5 | c9e093d7c1dca83f6546adaf3d874929e2cea612 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-06 | 176 | 61 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 180 | 61 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.58e-06 | 192 | 61 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 6.75e-06 | 193 | 61 | 5 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.75e-06 | 193 | 61 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-06 | 199 | 61 | 5 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.83e-06 | 199 | 61 | 5 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-06 | 200 | 61 | 5 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 148 | 61 | 4 | f58804d24fe524b42b5090c8658050ea4b14793e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.70e-05 | 159 | 61 | 4 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 7.03e-05 | 161 | 61 | 4 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 8.48e-05 | 169 | 61 | 4 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.88e-05 | 171 | 61 | 4 | 0f8d038858a4618b4348becc26a618d43b10d9d6 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-05 | 171 | 61 | 4 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.88e-05 | 171 | 61 | 4 | 791d37fe94ff2820fb409bbd38b31799df700ba1 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-05 | 171 | 61 | 4 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.88e-05 | 171 | 61 | 4 | 0bf36930bd7fc63691f48a15db93deb1dd937c10 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-05 | 173 | 61 | 4 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 174 | 61 | 4 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 177 | 61 | 4 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 177 | 61 | 4 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.01e-04 | 177 | 61 | 4 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 177 | 61 | 4 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 177 | 61 | 4 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.08e-04 | 180 | 61 | 4 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.15e-04 | 183 | 61 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 183 | 61 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.20e-04 | 185 | 61 | 4 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 1.23e-04 | 186 | 61 | 4 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.28e-04 | 188 | 61 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 188 | 61 | 4 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 61 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 191 | 61 | 4 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-04 | 192 | 61 | 4 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 194 | 61 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 194 | 61 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.47e-04 | 195 | 61 | 4 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.50e-04 | 196 | 61 | 4 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 1.50e-04 | 196 | 61 | 4 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.50e-04 | 196 | 61 | 4 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early|World / Primary Cells by Cluster | 1.50e-04 | 196 | 61 | 4 | dd3c6ea5e4ebcc27064f16507de6db6dc8f86fa8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 196 | 61 | 4 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | mild-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-04 | 196 | 61 | 4 | 9c351306b6aae68ed47d4cb1911957bf67f9e1ae | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 1.50e-04 | 196 | 61 | 4 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early-1|World / Primary Cells by Cluster | 1.50e-04 | 196 | 61 | 4 | 70fe6a1a6de891832aaa6276c985b326985e14db | |
| ToppCell | MS-mono1|MS / Condition, Cell_class and T cell subcluster | 1.53e-04 | 197 | 61 | 4 | 32be48ee2a1397ed8f1ee8e60067dd9a96bece39 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 197 | 61 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | MS-mono1-|MS / Condition, Cell_class and T cell subcluster | 1.53e-04 | 197 | 61 | 4 | 4b038a193ecc1df65bcb608091c513ddafd6c818 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.53e-04 | 197 | 61 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 197 | 61 | 4 | 05e303fff86db31f7b742324c64980eb2b9cff9a | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.53e-04 | 197 | 61 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 197 | 61 | 4 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.53e-04 | 197 | 61 | 4 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-04 | 198 | 61 | 4 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-04 | 198 | 61 | 4 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 198 | 61 | 4 | 3cc9e671f596ef0829684018e4257571fefb6267 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 198 | 61 | 4 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 61 | 4 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 199 | 61 | 4 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.59e-04 | 199 | 61 | 4 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1-SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.59e-04 | 199 | 61 | 4 | 7437bc48a803ab8f153e5516a0aa0391ae3d97c7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 199 | 61 | 4 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-04 | 199 | 61 | 4 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.59e-04 | 199 | 61 | 4 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-04 | 199 | 61 | 4 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.59e-04 | 199 | 61 | 4 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 199 | 61 | 4 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 199 | 61 | 4 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 199 | 61 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.62e-04 | 200 | 61 | 4 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 200 | 61 | 4 | 8c4c396e99be6131a8fa60d86214d561031b12bf | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-04 | 200 | 61 | 4 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | 5'-Airway_Nasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 200 | 61 | 4 | f6e967738b4f7b173d6e9977e305f77380dd6c8a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 200 | 61 | 4 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-04 | 200 | 61 | 4 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | 5'-Airway_Nasal-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 200 | 61 | 4 | 358d71329921451c7f5a56f1db0f9989af2299dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 200 | 61 | 4 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| Computational | Genes in the cancer module 4. | 1.26e-04 | 21 | 51 | 3 | MODULE_4 | |
| Computational | Genes in the cancer module 82. | 1.90e-04 | 24 | 51 | 3 | MODULE_82 | |
| Disease | Pseudoaphakia | 1.49e-05 | 24 | 59 | 3 | C0524524 | |
| Disease | Lens Opacities | 1.49e-05 | 24 | 59 | 3 | C1510497 | |
| Disease | Cataract | 5.62e-05 | 37 | 59 | 3 | C0086543 | |
| Disease | alkaline phosphatase measurement | 1.74e-04 | 1015 | 59 | 9 | EFO_0004533 | |
| Disease | uric acid measurement | 2.10e-04 | 610 | 59 | 7 | EFO_0004761 | |
| Disease | Microcephaly | 3.32e-04 | 67 | 59 | 3 | C0025958 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.63e-04 | 16 | 59 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Arthrogryposis | 8.05e-04 | 21 | 59 | 2 | C0003886 | |
| Disease | Carcinoma of lung | 9.68e-04 | 23 | 59 | 2 | C0684249 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 1.24e-03 | 26 | 59 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | indole-3-propionate measurement | 1.34e-03 | 27 | 59 | 2 | EFO_0010501 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 1.34e-03 | 27 | 59 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | Child Development Disorders, Specific | 1.54e-03 | 29 | 59 | 2 | C0085997 | |
| Disease | Child Development Deviations | 1.54e-03 | 29 | 59 | 2 | C0085996 | |
| Disease | Developmental Disabilities | 1.65e-03 | 30 | 59 | 2 | C0008073 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.99e-03 | 33 | 59 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 1.99e-03 | 447 | 59 | 5 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFEGGTFKLELFLPE | 46 | P61088 | |
| FFLGPKFKKLQDEGS | 526 | O00400 | |
| FKSDPFKGADPFKGD | 626 | Q9UBC2 | |
| FKGADPFKGDPFQND | 631 | Q9UBC2 | |
| SGDPFQSKKGFGDPF | 821 | Q9UBC2 | |
| DLKPVQDFFGLAFPG | 2151 | O95477 | |
| KFSVPGFKAEGPEVD | 756 | Q09666 | |
| FGNTPPPQKKEDDFL | 186 | Q8N6T3 | |
| LFPSDGFRDCKKGDP | 226 | P78545 | |
| PKYKDNPFSLGESFG | 356 | Q8N6H7 | |
| DFQEGDFFKDPLPEA | 231 | P46597 | |
| NTPKPSFFDFEGKQK | 81 | Q9BR61 | |
| ADPNFGFEEGKPCFI | 166 | P51164 | |
| AEFDEGFKVPGFLFK | 491 | Q03468 | |
| KLLFAEPKDAGFPFS | 136 | Q7L4S7 | |
| FKPGKEFFPLDESGN | 116 | P15121 | |
| GKESVFFAEPPFKAE | 301 | Q9P0K7 | |
| GGNAKDFSPGLFEDP | 676 | Q7Z5J4 | |
| KLFGFKEDPFVFIPE | 511 | Q08J23 | |
| IPKFKGPGDTSNFDD | 316 | P17612 | |
| LDPGPGAGDFKKFER | 631 | Q92619 | |
| FDEDGDKPPDFLGKV | 576 | Q6DN12 | |
| AFDPFLGGKNFDEKL | 226 | Q92598 | |
| NFGEEEFKFPPKDGF | 241 | Q92499 | |
| EFKFPPKDGFVALSK | 246 | Q92499 | |
| LSGGFEKNPKPIFTE | 301 | Q8NCN5 | |
| EDFVKPKGAFKAFTG | 241 | Q9UNZ2 | |
| SGPIKDKNSFPFFAS | 1076 | Q6R327 | |
| SFGHFPGPEFLDVEK | 176 | Q8IWW6 | |
| GDSGTGEFKFLKPIF | 756 | Q9Y5E5 | |
| NLPSGKFPRGFKFDT | 556 | P50993 | |
| FKSGFEPPGDFPFED | 271 | Q5T0N5 | |
| QFKSFPEISFLGPKD | 246 | Q8NFT6 | |
| FGPALPPGFKKQDDS | 91 | Q8IXQ4 | |
| FPEGKAQFADIEPKF | 346 | Q9GZT9 | |
| PEDPTKKGDLFIFFD | 281 | P59910 | |
| GGPLKFSEKFQLFTP | 121 | O43921 | |
| PEGGETPLFKQFFKN | 381 | P06396 | |
| RKFPAGKVPAFEGDD | 51 | P26641 | |
| VGSDPFKDDPFGKID | 626 | P42566 | |
| FKDDPFGKIDPFGGD | 631 | P42566 | |
| KEFFNGKEPSRGINP | 376 | P11021 | |
| GGEAPSKPKDSSFFD | 181 | O75363 | |
| ALDFLGFGFSDKPRP | 101 | Q5EB52 | |
| DDPNFIPFGGDTKSG | 411 | Q9Y6A5 | |
| GKPEKFSFGLLDLPF | 821 | A6NHR9 | |
| PGVFGALQNFKEDKP | 656 | O75151 | |
| LPEGGETPIFKQFFK | 331 | Q9Y6U3 | |
| PGMFPFKDKFGLFAE | 196 | Q8WTV0 | |
| DKFKDDPVGPFGQES | 636 | Q9UHV7 | |
| FKTGDDFFPKDDKGN | 116 | C9JRZ8 | |
| PDGPFPQDEKLKDAF | 91 | Q9H6E4 | |
| GKEFGVATNTFFKPP | 141 | P49767 | |
| VDFEGTDEPIFGKKP | 66 | P42285 | |
| PGEPQVFLGKDKAFT | 36 | Q7Z4S6 | |
| GLKELYEKGPPNAFF | 281 | Q99594 | |
| FGPEGTPFEDGTFKL | 41 | P49459 | |
| SDGGLFVPAKEFPKL | 261 | Q8IYQ7 | |
| GGFDKPPSEYFPIKD | 741 | Q14997 | |
| TIGPAQPFFKEEKEG | 181 | Q9UFB7 | |
| PNDFFKDMFPDLPGG | 306 | A1YPR0 | |
| IDNGFFSPKQPDLFK | 746 | P06737 | |
| FGPEGTPFEDGTFKL | 41 | P63146 | |
| PGKFPSGKTEIPFEF | 81 | O14972 | |
| DEFPTDIPGTKGNFK | 111 | P41091 |